2 results match your criteria: "The University of Vienna School of Medicine[Affiliation]"
Burkitt lymphoma following splenic marginal zone lymphoma. evidence for two independent B-cell clones.
Cancer Genet Cytogenet
February 2003
Division of Hematology and Hemostaseology, Department of Internal Medicine I, The University of Vienna School of Medicine, Vienna, Austria.
We report the progression of splenic marginal zone lymphoma (SMZL) with circulating villous lymphocytes to Burkitt lymphoma with the presence of a t(8;14)(q24;q32) followed by a highly aggressive course. While the initial indolent lymphoma had an IgM lambda immunophenotype the Burkitt lymphoma was IgM kappa-positive. Immunoglobulin heavy chain gene (IGH) sequence analysis showed no identity between the two clones.
View Article and Find Full Text PDFAssociation of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
Leuk Lymphoma
August 2002
Department of Internal Medicine I, The University of Vienna School of Medicine, Austria.
The expression of the surface molecule CD38 on B cell chronic lymphocytic leukemia (B-CLL) cells has recently been described as a prognostic marker for patient survival. We have analyzed CD19/CD38 expression in 81 patients with predominantly early stages of B-CLL (69 Binet A, seven Binet B, five Binet C). Sixty-two patients (77%) had less than 30% CD38+/CD19+ cells, while 19 (23%) had > or = 30%.
View Article and Find Full Text PDF